信息搜索
信息关键字:药
 

共有4382条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]

·鲁抗医药拟4200万收购大地药业70%股权2011-12-20 22:06:33
·南京医药澄清媒体关于资产大甩卖传闻2011-12-20 22:02:28
·恒瑞医药:伊立替康注射液通过FDA认证2011-12-20 17:18:04
·发改委:11月农药原药产量24万吨 同增22.4%2011-12-20 16:36:20
·恒瑞医药:伊立替康注射液通过美国FDA认证2011-12-20 16:32:01
·恒瑞医药:伊立替康注射液通过FDA认证2011-12-20 16:07:02
·云南白药股权转让审批卡壳 陈发树被指胜算不大2011-12-20 15:50:50
·东北证券:医药行业结构化行情值得期待2011-12-20 13:49:38
·农业部张榜农药不合格企业 多家上市公司在列2011-12-20 13:36:30
·白云山制药牵手钟南山研发一类新药2011-12-20 12:59:07
·恒瑞医药成国内首家获美国FDA认证公司2011-12-20 9:27:23
·乙型血友病救命药断货卫生部急调万支投放市场2011-12-20 8:57:33
·江中药业(600750)2011-12-20 8:54:41
·华兰生物血浆站事件发酵:血友病治疗药物告急2011-12-20 8:41:27
·南京医药1亿元增资中健之康公司2011-12-19 22:27:22
·海南海药控股子公司拟收购开元医药75%股权2011-12-19 21:37:16
·海南制药控股子公司拟收购开元医药75%股权2011-12-19 20:38:39
·*ST吉药核查异动 无未披露重大事项2011-12-19 19:36:11
·双鹭药业:加强在糖尿病领域的研发实力2011-12-19 17:13:38
·双鹭药业:布局糖尿病用药市场2011-12-19 16:56:54

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220]